ArticleJournal of diabetes investigation2026
Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reappraising Kidney Biopsy in Diabetic Kidney Disease: Histopathology, Clinical Course, and the Future of Precision Nephrology.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo explore the association between serum fibrinogen (FIB) and clinicopathological features and renal prognosis in type 2 diabetic nephropathy (T2DN), and develop a web-based dynamic model to predict renal progression.
methodsThis paper retrospectively enrolled 173 biopsy-proven T2DN patients and stratified them by the optimal FIB cutoff. Renal progression was defined as a >50% decline in eGFR, doubling of creatinine, or onset of end-stage renal disease (ESRD). Cox regression analysis was used to screen out the independent predictors of T2DN progression; a web-based dynamic prediction model was established and evaluated using time-dependent receiver operating characteristic (Time-ROC) curves, calibration curves, and decision curve analysis (DCA).
resultsOf the 173 patients, 81 (46.82%) experienced the renal endpoint event. Multifactorial Cox regression analysis showed that eGFR, hemoglobin, FIB, parathyroid hormone, and interstitial fibrosis and tubular atrophy (IFTA) scores were independent risk factors for T2DN progression (P < 0.05). Among the three models constructed based on these factors, model 3 had the highest areas under the curve (AUC) (90.42; 95% CI, 85.80-95.04). The AUC of the risk prediction model constructed by the nomogram was 0.846, 0.752, and 0.754 at 1, 3, and 5 years, showing good discrimination, and the Web-based dynamic nomogram demonstrated good calibration.
conclusionsFIB is an independent predictor of T2DN progression. A web-based dynamic model was developed to predict renal progression risk in T2DN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.